. 2022 Jun 28;28(24):2654–2666. doi: 10.3748/wjg.v28.i24.2654
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
Figure 2.
Bilirubin and alanine transaminase trend for patients A and B. A: Patient A; B: Patient B.